v3.26.1
CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
6 Months Ended
Apr. 30, 2026
Apr. 30, 2025
Cash Flow from Operating Activities    
Net loss $ (582,894) $ (5,931,459)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 128,653 111,988
Non cash interest expenses 12,531 0
Legal services provided in exchange for convertible note 0 45,000
Loss on write-off of intangible asset 0 105,190
(Gain)/Loss on fair value of convertible note 88,160 14,985
(Gain)/Loss on derivative liability 9,214  
Share based compensation 0 5,092,557
Changes in operating assets and liabilities:    
(Increase)/Decrease in accounts receivable 332,669 (8,450)
Decrease in other receivable 1,000 0
(Decrease) in accounts payable (340,023) (106,116)
Increase/(Decrease) in accrued payroll 0 (8,881)
Increase in accrued interest payable 13,637 13,864
Operating lease ROU assets and lease liabilities, net (634) 125
Net Cash Used in Operating Activities (337,687) (671,197)
Cash Flows from Financing Activities    
Proceeds from related party advances 230,000 509,000
Repayment of related party advances (30,000) (150,000)
Proceeds from sale of common stock subscription payable 60,000 0
Proceeds from sale of common stock 62,500 542,500
Proceeds from issuance of convertible notes payable 314,500 0
Repayment of convertible notes payable (150,000) 0
Net Cash Provided by Financing Activities 487,000 901,500
Cash Flows from Investing Activities    
Purchase of property and equipment (13,168) (177,944)
Net Cash Used in Investing Activities (13,168) (177,944)
Net increase (decrease) in cash 136,145 52,359
Cash at beginning of period 9,525 20,255
Cash at end of period 145,670 72,614
Supplemental Disclosure for Cash Paid:    
Lease liability paid during the period 31,089 0
Income taxes paid during the period 0 0
Interest paid during the period 897 0
Supplemental Disclosure for Non-Cash Investing and Financing Activities:    
Property and equipment acquired through accounts payable 348,845 398,845
Common stock cancellation per share exchange agreement 0 (360,000)
Series B preferred stock issuance per exchange agreement 0 360,000
Shares issued for redemption of convertible notes payable 47,446 0
Convertible note issued in exchange for legal services, recorded at fair value 0 59,985
Derivative liability balance $ 192,500 $ 0